IndraLab

Statements


| 4

reach
"Gao et al. (84) found high USP29, HIF1α and GLUT1 levels in sorafenib-resistant PDX tumours, and follow-up research revealed that USP29-induced sorafenib resistance by mediating HIF1α stabilisation and upregulated glycolysis."

reach
"USP29 promotes sorafenib resistance in vivo."

reach
"USP29 promotes sorafenib resistance in HCC cells by stabilizing HIF1α [22]."

reach
"Together, the data demonstrate that, as a DUB of HIF1alpha, USP29 promotes Sorafenib resistance in HCC cells, in parts by upregulating glycolysis, thereby opening new avenues for therapeutically targeting Sorafenib-resistant HCC in patients."